Vigil Neuro
Jordan Jara is a Clinical Trial Manager with extensive experience in overseeing clinical studies across multiple organizations, including Vigil Neuroscience and Praxis Precision Medicines, Inc. Proficient in maintaining trial documentation, regulatory compliance, and providing oversight to Clinical CROs, Jordan has successfully managed various high-profile projects in collaboration with major pharmaceutical companies. Previous roles include positions at Takeda as a Senior Clinical Trial Associate and Clinical Research Associate, as well as a Senior Clinical Research Coordinator at Lahey Hospital & Medical Center, where responsibilities encompassed training research teams, coordinating industry-sponsored studies, and ensuring adherence to regulatory guidelines. Jordan holds a Bachelor of Science in Neuroscience from The University of Vermont and possesses a strong background in clinical research and trial management.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.